Current role of LC-MS in therapeutic drug monitoring

被引:99
作者
Saint-Marcoux, Franck [1 ]
Sauvagge, Francois-Ludovic [1 ]
Marquet, Pierre [1 ]
机构
[1] Univ Limoges Hosp, Dept Pharmacol Toxicol, INSERM, Unite U850, F-87042 Limoges, France
关键词
therapeutic drug monitoring; liquid chromatography; mass spectrometry;
D O I
10.1007/s00216-007-1320-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The role of liquid chromatography coupled with mass spectrometry (LC-MS) techniques in routine therapeutic drug monitoring activity is becoming increasingly important. This paper reviews LC-MS methods published in the last few years for certain classes of drugs subject to therapeutic drug monitoring: immunosuppressants, antifungal drugs, antiretroviral drugs, antidepressants and antipsychotics. For each class of compounds, we focussed on the most interesting methods and evaluated the current role of LC-MS in therapeutic drug monitoring.
引用
收藏
页码:1327 / 1349
页数:23
相关论文
共 161 条
  • [1] Therapeutic drug monitoring - An aid to optimising response to antiretroviral drugs?
    Aarnoutse, RE
    Schapiro, JM
    Boucher, CAB
    Hekster, YA
    Burger, DM
    [J]. DRUGS, 2003, 63 (08) : 741 - 753
  • [2] High-performance liquid chromatography of HIV protease inhibitors in human biological matrices
    Aarnoutse, RE
    Wissen, CPWGMVV
    Underberg, WJM
    Kleinnijenhuis, J
    Hekster, YA
    Burger, DM
    [J]. JOURNAL OF CHROMATOGRAPHY B, 2001, 764 (1-2): : 363 - 384
  • [3] Position paper on therapeutic drug monitoring of antiretroviral agents
    Acosta, EP
    Gerber, JG
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (12) : 825 - 834
  • [4] Rapid liquid chromatography-tandem mass spectrometry method for quantification of ziprasidone in human plasma
    Al-Dirbashi, OY
    Aboul-Enein, HY
    Al-Odaib, A
    Jacob, M
    Rashed, MS
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2006, 20 (04) : 365 - 368
  • [5] Interference by venlafaxine ingestion in the detection of tramadol by liquid chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human urine
    Allen, KR
    [J]. CLINICAL TOXICOLOGY, 2006, 44 (02): : 147 - 153
  • [6] Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals
    Almond, LM
    Edirisinghe, D
    Dalton, M
    Bonington, A
    Back, DJ
    Khoo, SH
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (02) : 132 - 142
  • [7] Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry
    Annesley, TM
    Clayton, LT
    [J]. CLINICAL CHEMISTRY, 2005, 51 (05) : 872 - 877
  • [8] Ion suppression in mass spectrometry
    Annesley, TM
    [J]. CLINICAL CHEMISTRY, 2003, 49 (07) : 1041 - 1044
  • [9] [Anonymous], 2005, Clinical and Applied Immunology Reviews
  • [10] Aravagiri M, 2000, J MASS SPECTROM, V35, P718, DOI 10.1002/1096-9888(200006)35:6<718::AID-JMS999>3.0.CO